Trials / Completed
CompletedNCT00654888
Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy
Study of Automated Lamellar Keratectomy With a New Option in Treatment in Symptomatic Patients With Bullous Keratopathy.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Federal University of São Paulo · Academic / Other
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
To relieve pain in patients with symptomatic bullous keratopathy (BK) until keratoplasty and in patients without visual prediction. The automated lamellar keratectomy represents a alternative in treatment of pain in symptomatic patients with BK.
Detailed description
Only patients with BK symptomatic (with pain) were submitted to automated lamellar keratectomy (ALK). Complete ophthalmological examination including UCVA,BSVA, biomicroscopy, tonometry, esthesiometry, UBM pachymetry, impression cytology and pain questionnaire were performed in preoperative, postoperative of one, seven, 30, 90, 180 days and one year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ALK (automated lamellar keratectomy) | ALK is performed with a microkeratome, to make a free cap. |
| DRUG | Mitomycin | mitomycin 0,02%, 30 seconds after ALK |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2006-03-01
- Completion
- 2008-02-01
- First posted
- 2008-04-09
- Last updated
- 2008-04-11
Source: ClinicalTrials.gov record NCT00654888. Inclusion in this directory is not an endorsement.